Pharmaceuticals: who decides the price of life?

The cystic fibrosis drug Orkambi could extend the lives of thousands of children – but it comes with a price tag of £105,000 per patient per year. The NHS says it cannot afford it. Health editor Sarah Boseley explores how the cost of a life-extending drug can be weighed next to a person’s life. Plus: Natalie Nougayrède on the conspiracy theories threatening European unity. To support The Guardian’s independent journalism, visit <a href="https://www.theguardian.com/todayinfocus/support">theguardian.com/todayinfocus/support</a>